These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Comparative clinical outcomes between direct oral anticoagulants and warfarin among elderly patients with non-valvular atrial fibrillation in the CMS medicare population. Amin A, Keshishian A, Dina O, Dhamane A, Nadkarni A, Carda E, Russ C, Rosenblatt L, Mardekian J, Yuce H, Baker CL. J Thromb Thrombolysis; 2019 Aug; 48(2):240-249. PubMed ID: 30924051 [Abstract] [Full Text] [Related]
24. Effectiveness and Safety of Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation and Diabetes Mellitus. Lip GYH, Keshishian AV, Kang AL, Li X, Dhamane AD, Luo X, Balachander N, Rosenblatt L, Mardekian J, Nadkarni A, Pan X, Di Fusco M, Garcia Reeves AB, Yuce H, Deitelzweig SB. Mayo Clin Proc; 2020 May; 95(5):929-943. PubMed ID: 32370854 [Abstract] [Full Text] [Related]
25. Oral anticoagulants for nonvalvular atrial fibrillation in frail elderly patients: insights from the ARISTOPHANES study. Lip GYH, Keshishian AV, Kang AL, Dhamane AD, Luo X, Li X, Balachander N, Rosenblatt L, Mardekian J, Pan X, Di Fusco M, Garcia Reeves AB, Yuce H, Deitelzweig S. J Intern Med; 2021 Jan; 289(1):42-52. PubMed ID: 32602228 [Abstract] [Full Text] [Related]
26. Comparative Stroke, Bleeding, and Mortality Risks in Older Medicare Patients Treated with Oral Anticoagulants for Nonvalvular Atrial Fibrillation. Graham DJ, Baro E, Zhang R, Liao J, Wernecke M, Reichman ME, Hu M, Illoh O, Wei Y, Goulding MR, Chillarige Y, Southworth MR, MaCurdy TE, Kelman JA. Am J Med; 2019 May; 132(5):596-604.e11. PubMed ID: 30639551 [Abstract] [Full Text] [Related]
27. Effectiveness and Safety of Apixaban, Dabigatran, and Rivaroxaban Versus Warfarin in Frail Patients With Nonvalvular Atrial Fibrillation. Martinez BK, Sood NA, Bunz TJ, Coleman CI. J Am Heart Assoc; 2018 Apr 13; 7(8):. PubMed ID: 29654196 [Abstract] [Full Text] [Related]
32. Comparative Effectiveness and Safety of Direct Oral Anticoagulants and Warfarin in Patients With Atrial Fibrillation and Chronic Liver Disease: A Nationwide Cohort Study. Lawal OD, Aronow HD, Shobayo F, Hume AL, Taveira TH, Matson KL, Zhang Y, Wen X. Circulation; 2023 Mar 07; 147(10):782-794. PubMed ID: 36762560 [Abstract] [Full Text] [Related]
33. Reduced dose direct oral anticoagulants compared with warfarin with high time in therapeutic range in nonvalvular atrial fibrillation. Jansson M, Själander S, Sjögren V, Björck F, Renlund H, Norrving B, Själander A. J Thromb Thrombolysis; 2023 Apr 07; 55(3):415-425. PubMed ID: 36607464 [Abstract] [Full Text] [Related]
34. Oral Anticoagulants for Nonvalvular Atrial Fibrillation in Patients With High Risk of Gastrointestinal Bleeding. Lip GYH, Keshishian AV, Zhang Y, Kang A, Dhamane AD, Luo X, Klem C, Ferri M, Jiang J, Yuce H, Deitelzweig S. JAMA Netw Open; 2021 Aug 02; 4(8):e2120064. PubMed ID: 34398204 [Abstract] [Full Text] [Related]
35. The risk of stroke/systemic embolism and major bleeding in Asian patients with non-valvular atrial fibrillation treated with non-vitamin K oral anticoagulants compared to warfarin: Results from a real-world data analysis. Bang OY, On YK, Lee MY, Jang SW, Han S, Han S, Won MM, Park YJ, Lee JM, Choi HY, Kang S, Suh HS, Kim YH. PLoS One; 2020 Aug 02; 15(11):e0242922. PubMed ID: 33253294 [Abstract] [Full Text] [Related]
40. Effectiveness and safety of oral anticoagulants in older adults with non-valvular atrial fibrillation and heart failure. Amin A, Garcia Reeves AB, Li X, Dhamane A, Luo X, Di Fusco M, Nadkarni A, Friend K, Rosenblatt L, Mardekian J, Pan X, Yuce H, Keshishian A. PLoS One; 2019 Aug 02; 14(3):e0213614. PubMed ID: 30908512 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]